Radiologist fatigue affects breast imaging interpretationJanuary 24, 2022Breast CancerMetastatic Breast Cancer
The evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapiesDecember 11, 2021Breast CancerMetastatic Breast Cancer
Liquid biopsy in metastatic breast cancer management: Where does it stand in clinical practice?November 7, 2021Breast CancerMetastatic Breast Cancer
Biomarker testing in metastatic breast cancer management: ‘Essential’October 6, 2021Metastatic Breast CancerBreast Cancer
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancerSeptember 30, 2021Breast CancerMetastatic Breast Cancer
Treatment shows 'important improvements' in triple-negative breast cancerSeptember 30, 2021Breast CancerMetastatic Breast Cancer
Better survival with extended letrozole in early-stage breast cancerSeptember 29, 2021Breast CancerMetastatic Breast Cancer
Twelve-month overall survival benefit with ribociclib for metastatic breast cancerSeptember 21, 2021Breast CancerMetastatic Breast Cancer
Polygenic breast cancer risk scores strive to overcome racial biasAugust 24, 2021Breast CancerMetastatic Breast Cancer
Key strategies for managing breast cancer brain metastasesJune 17, 2021Metastatic Breast CancerBreast Cancer
CONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancerJune 7, 2021Breast CancerMetastatic Breast Cancer
IL-6 levels predict distant breast cancer recurrenceJune 4, 2021Metastatic Breast CancerBreast Cancer
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first yearJune 2, 2021Metastatic Breast CancerBreast Cancer
Endocrine therapy benefits in premenopausal breast cancer differ by molecular riskMay 26, 2021Breast CancerMetastatic Breast Cancer
